Related by context. All words. (Click for frequent words.) 78 Patients Undergoing 78 Acute Ischemic Stroke 77 Percutaneous Coronary Intervention 77 Prospective Randomized 77 Myocardial Infarction 76 Thrombolysis 76 Ischemic Stroke 76 Infarction 75 Coronary Artery Bypass Graft 75 Patients Treated 74 Myocardial Infarction Study 74 Severe Sepsis 74 Prospective Multicenter 74 Carotid Stenting 74 Acute Coronary Syndromes 74 Heart Failure Patients 74 Infarct 73 Stent Thrombosis 73 Unstable Angina 73 Acute Myocardial 73 Pivotal Trial 73 Venous Thromboembolism 73 Diabetic Patients 73 Patient Outcomes 73 Randomized Evaluation 72 Oral Fingolimod 72 Acute Coronary Syndrome 72 Left Ventricular 72 Pooled Analysis 72 Platelet Inhibition 72 Patients Treated With 72 Relapsing Multiple Sclerosis 72 Dual Antiplatelet Therapy 72 Improves Survival 72 Stenting 72 Coronary Angiography 72 Study Evaluating 72 Carotid Endarterectomy 72 Elderly Patients 72 ST Segment Elevation 72 Renal Artery 72 Renal Cell Carcinoma 72 Subgroup Analysis 72 Improves Outcomes 72 Adjuvant Chemotherapy 72 Randomized Study 72 Chronic Heart Failure 71 Stent Restenosis 71 Intracerebral Hemorrhage 71 ST Elevation Myocardial 71 Randomized Clinical Trial 71 Cardiovascular Events 71 Combination Treatment 71 Phase III Trial 71 Cardiac Resynchronization 71 Myocardial Ischemia 71 Cardiogenic Shock 71 Long Term Efficacy 71 Stent Implantation 71 Phase III Clinical Trial 71 Drug Eluting Stents 71 Radiofrequency Ablation 71 Cardiovascular Outcomes 71 Carotid 71 Adjuvant Therapy 71 Angiographic 71 Reperfusion 71 Controlled Trial 71 Clinical Trial Evaluating 71 Radical Prostatectomy 71 Metastatic Colorectal Cancer 71 Clinical Trial Results 71 Newly Diagnosed Multiple Myeloma 70 Patency 70 Acute Decompensated Heart Failure 70 II Clinical Trial 70 Risk Stratification 70 Multicenter Study 70 Overactive Bladder 70 Ischemic 70 Unfractionated Heparin 70 Metastatic Renal Cell Carcinoma 70 Heart Failure Trial 70 Autologous Stem Cell Transplantation 70 Clinical Efficacy 70 Myelodysplastic Syndromes 70 Val HeFT 70 Recurrent Stroke 70 Cardiac Resynchronization Therapy 70 Pivotal Clinical Trial 70 Robotic Assisted 70 Carotid Revascularization Endarterectomy vs. 70 Rheumatoid Arthritis Patients 70 Catheter Ablation 70 Patients Receiving 70 Meets Primary Endpoint 70 Aggressive Reduction 70 Localized Prostate Cancer 70 Completes Enrollment 70 Pulmonary Arterial Hypertension 70 Aortic Dissection 70 RENAL 70 Bivalirudin 70 Knee Osteoarthritis 70 Coronary Artery 69 Reduces Mortality 69 Metastatic Prostate Cancer 69 Neoadjuvant Chemotherapy 69 Prospective Randomized Trial 69 CT Angiography 69 Septic Shock 69 Multicenter 69 Hemodialysis Patients 69 Gastric Cancer 69 Randomized Controlled Trial 69 Intracranial Aneurysms 69 Phase 2b Study 69 Hepatocellular Carcinoma 69 Clinical Outcome 69 Chronic Hepatitis C 69 Pegylated Liposomal Doxorubicin 69 ExTRACT TIMI 69 Advanced Melanoma 69 Ranolazine 69 Unresectable 69 Breast Cancer Recurrence 69 Solid Tumors 69 Demonstrates Positive 69 Postmenopausal Women 69 Is Well Tolerated 69 Eluting Stent 69 Drug Eluting 69 Relapsing Remitting Multiple Sclerosis 69 Endarterectomy 69 Intravascular 69 Occlusive Disease 69 Surgical Treatment 69 Stable Angina 69 Improve Survival 69 First Patient Enrolled 69 Aortic Valve Replacement 69 NAVISTAR R 69 Relapsed Multiple Myeloma 69 Anticoagulation 68 Peripheral Arterial 68 Colorectal Cancer Patients 68 Acute Heart Failure 68 Thromboembolism 68 Statin Therapy 68 Survival Benefit 68 Obese Patients 68 Aortic Stenosis 68 Prolongs Survival 68 Refractory Angina 68 Left Ventricular Dysfunction 68 Castration Resistant Prostate Cancer 68 Phase 2b Clinical Trial 68 Ventricular Tachycardia 68 Controlled Study 68 Hormone Refractory Prostate Cancer 68 Metastatic Melanoma 68 RE LY 68 STENT 68 Pivotal Phase III 68 Lung Cancer Patients 68 Aggressive Drug Evaluation 68 Meta Analysis 68 Well Tolerated 68 Randomized Phase 68 Complicated Skin 68 Hormone Receptor Positive 68 Pediatric Patients 68 EVEREST II 68 Congestive Heart Failure 68 HER2 Positive Breast Cancer 68 Bare Metal Stents 68 Observational Study 68 Coronary Artery Bypass Surgery 68 Fondaparinux 68 Abciximab 68 Combination REOLYSIN R 68 Pivotal Study 68 Post Operative 68 Decompensated Heart Failure 68 Venous Thrombosis 68 Randomized Double Blind 68 Prostate Cancer Patients 68 Cypher Sirolimus 68 Chronic Sinusitis 68 CLARITY TIMI 68 Hypertensive Patients 68 Invasive Breast Cancer 68 Severe Asthma 68 Less Invasive 67 Sirolimus Eluting Stent 67 Phase IIb Trial 67 Intracranial 67 Novel Oral 67 Neoadjuvant 67 Adjuvant Treatment 67 Investigational Agent 67 Lung Injury 67 Guideline Update 67 Randomized Controlled 67 Prostate Cancer Treatment 67 Patient Enrollment 67 Pivotal Phase 67 Sustained Efficacy 67 Recurrent Breast Cancer 67 Multicenter Trial 67 Myocardial 67 Minimally Invasive Treatment 67 Node Positive 67 undergoing elective percutaneous 67 Aortic Valve 67 Phase IIb Clinical Trial 67 Clinical Outcomes 67 Breast Density 67 Sipuleucel T 67 Fungal Infections 67 Nesiritide 67 Coronary Stent 67 PREVAIL 67 Percutaneous Tibial Nerve Stimulation 67 Non Invasive 67 Valve Replacement 67 Intravitreal 67 Restenosis 67 Treating Chronic 67 Bone Mineral Density 67 Endeavor Drug Eluting 67 Bone Metastases 67 Renal Impairment 67 Antihypertensive 67 Antitumor Activity 67 Edge STudy 67 Study Showed 67 Liver Failure 67 Cognitive Impairment 67 Disease Progression 67 Multicenter Randomized 67 Bare Metal Stent 67 Systolic Hypertension 67 Patients Enrolled 67 fosbretabulin 67 Increased Mortality 67 Contrast Enhanced 67 Carotid Artery Stenting 67 Demonstrates Efficacy 67 Intracoronary 67 Dose Ranging Study 67 EURIDIS 67 dual endothelin receptor antagonist 67 Lipid Lowering Treatment 67 Appears Safe 67 Induction Therapy 67 Proves Effective 66 multicenter prospective 66 Heterozygous Familial Hypercholesterolemia 66 Microalbuminuria 66 Transcatheter 66 Brain Metastases 66 Paclitaxel Eluting 66 Aneurysm Repair 66 Enoxaparin 66 Cardiac Arrest Patients 66 Diastolic Heart Failure 66 Liver Metastases 66 Single Dose 66 Statistically Significant 66 Secondary Hyperparathyroidism 66 Monotherapy 66 Advanced Colorectal Cancer 66 Long Term Outcomes 66 Preclinical Study 66 SYNTAX 66 Immunosuppression 66 Cutaneous T 66 carotid artery stenting CAS 66 Coronary Intervention 66 Tiotropium 66 Cell Lymphoma 66 Chronic Myeloid Leukemia 66 ORLive Presents 66 Malignant Melanoma 66 Kidney Transplant Patients 66 Embolic Protection Device 66 Balloon Angioplasty 66 Investigational Drug 66 Improve Outcomes 66 Renal Function 66 complement inhibitor eculizumab 66 Randomized Trials 66 Antiplatelet Therapy 66 Prognostic Significance 66 undergoing coronary artery 66 Bladder Cancer 66 Outpatient Setting 66 multicenter randomized controlled 66 Bucindolol 66 STRIDE PD 66 Chronic Hepatitis B 66 Drug Eluting Stent 66 Randomized Phase II 66 Reperfusion Injury 66 Tyrosine Kinase Inhibitor 66 Clinical Outcomes Utilizing Revascularization 66 Pharmacokinetic Study 66 Atherosclerotic 66 PICSO ® 66 Thrombotic 66 Stereotactic Body Radiation Therapy 66 thrombus aspiration 66 Randomized Phase III 66 Prophylactic Treatment 66 Total Knee Arthroplasty 66 Chronic Renal Failure 66 Coronary Revascularization 66 SPIRIT FIRST 66 Cholesterol Levels SPARCL 66 MR Angiography 66 Randomized Double Blind Placebo 66 undergoing Percutaneous Coronary 66 Atypical Hemolytic Uremic Syndrome 66 Chronic Lymphocytic Leukemia 66 ARBITER 6 66 Dialysis Patients 66 CABG Surgery 66 Lung Cancer Trial 66 Non Invasive Treatment 66 Resection 66 prospective multicenter 66 Diabetic Nephropathy 66 Study Demonstrates 66 Nebulized 66 Investigational Treatment 66 Randomized Controlled Trials 65 Artery Disease 65 PRECISE 65 Treatment Resistant 65 Resistant Hypertension 65 Phase III Pivotal 65 Fixed Dose 65 Completes Patient Enrollment 65 unstable angina UA 65 Endovascular Repair 65 Phase 2a Clinical Trial 65 Glycemic Control 65 Placebo Controlled Trial 65 Preclinical Data 65 Lung Cancers 65 See CLINICAL PHARMACOLOGY 65 Echocardiographic 65 Radiation Dose 65 Cardiovascular Risk 65 Cardiotoxicity 65 Drug Prevents 65 Dose Escalation 65 Lupus Nephritis 65 acute PAO 65 atypical Hemolytic Uremic Syndrome 65 Survival Rates 65 Advanced Renal Cell 65 Acute Stroke 65 Ovarian Cancer Patients 65 Premature Infants 65 Fracture Risk 65 STICH 65 Pelvic Organ Prolapse 65 Follicular Lymphoma 65 Invasive Fungal Infections 65 PRoFESS 65 Prognostic Value 65 AA Amyloidosis 65 Sirolimus eluting Coronary Stent 65 Coronary Artery Bypass Grafting 65 Thrombolytic Therapy 65 Adenoma Prevention 65 CARE HF 65 Progenitor Cells 65 Implantable Cardioverter Defibrillator 65 Hospitalized Patients 65 JAK Inhibitor 65 DEFER 65 Heart Transplant Recipients 65 Orthostatic Hypotension 65 Events MACE 65 Clostridium difficile Infection 65 Initiate Phase 65 Vertebroplasty 65 HALTS 65 Catheterization 65 Critically Ill Patients 65 Stenting Trial CREST 65 Proven Effective 65 Postmenopausal 65 Advanced Heart Failure 65 Randomised Controlled Trial 65 Bosutinib 65 Tumor Response 65 Ischaemic 65 Endovascular Valve Edge 65 PROMUS TM 65 Prevent Stroke 65 Zoledronic Acid 65 Nilotinib 65 Clinical Trial Data 65 Insulin Therapy 65 Breast Cancer Patients 65 Ambulatory Blood Pressure 65 ASTEROID 65 Endovascular Treatment 65 Stenosis 65 Previously Treated 65 Teva Provides Update 65 Kidney Failure 65 Hormone Therapy 65 Preterm Delivery 65 Treatment Outcome 65 Breast Cancer Treatment 65 Double Blind Placebo 65 Boosts Survival 65 Clinical Evaluation 65 Inflammatory Markers 65 Randomised 65 acute myocardial infarction AMI 65 COPERNICUS 65 Idiopathic Pulmonary Fibrosis 65 multicentre randomized 65 Non Alcoholic Steatohepatitis 65 TAXUS ATLAS 65 Deep Venous Thrombosis 65 Treated Patients 65 sirolimus eluting stents 65 Investigational Compound 65 Arimidex Tamoxifen Alone 65 Breaking Clinical Trials 65 Demonstrates Significant 65 Stem Cell Treatment 65 Chronic Constipation 65 Successfully Treats 65 Multicenter Phase 65 Multiple Myeloma Patients 65 Gene Mutation 65 Tolerability 65 Hip Fracture 65 primary percutaneous coronary 65 Lung Tumors 65 Afib 65 Prostate Cancer Recurrence 64 Chemoradiation 64 Shows Efficacy 64 Intervention Trial 64 Soft Tissue Sarcoma 64 Progressive Multifocal Leukoencephalopathy 64 Virtual Colonoscopy 64 FDA Approvals 64 Shows Promising 64 Myeloma Patients 64 Uterine Fibroid Embolization 64 Predict Risk 64 Nicotine Vaccine 64 Renal Failure 64 Tumor Growth 64 Osteoarthritis Patients 64 Bevacizumab 64 See WARNINGS 64 REMINDER ORLive Presents 64 Malignant Glioma 64 Delayed Graft Function 64 Treating Heart Failure 64 Ventricular 64 ACUITY trial 64 Phase 2b Trial 64 Skeletal Muscle 64 icatibant 64 Antiviral Activity 64 Demonstrates Sustained 64 Systolic Blood Pressure 64 Cryoablation 64 Diabetic Neuropathy 64 Patients Suffering 64 GOUT 64 Ejection Fraction 64 Circulating Tumor Cells 64 Endometrial Cancer 64 ACE Inhibitors 64 Drug Shows Promise 64 Inhaled Corticosteroids 64 Clinical Study 64 Combination Therapy 64 Primary Hypercholesterolemia 64 Plus Ribavirin 64 Prostatectomy 64 Hernia Repair 64 Reduced Incidence 64 Hypotension 64 Beta Blocker 64 Schizophrenia Treatment 64 Improved Survival 64 EchoCRT 64 Oral Mucositis 64 Drug Candidate 64 Ischemia 64 Glatiramer Acetate 64 Kidney Function 64 ATACAND 64 Receives Orphan Drug Designation 64 patients undergoing percutaneous 64 Cardiac Arrhythmias 64 Cardiac Allograft Rejection 64 Metabolic Efficiency 64 Renal Anemia 64 Advanced Prostate Cancer 64 Cancer Patients Treated 64 Complete Remission 64 Antiplatelet 64 Embolic 64 Myocardial Infarction TIMI 64 J Am Coll 64 Low Dose 64 Carcinoma 64 Atrial 64 First Patient Dosed 64 Treatment Naive Patients 64 Novel Inhibitor 64 Efficacy Trial 64 MEND CABG 64 Demonstrate Significant 64 Valsartan 64 First Patient Treated 64 Circulatory Support 64 Laryngeal Cancer 64 ACTEMRA TM 64 unfractionated heparin UFH 64 Myelofibrosis 64 Randomized Double blind 64 Genes Predict 64 Total Knee Replacement 64 failure ADHF 64 Endothelial Function 64 Adult Stem Cell Therapy 64 Non Alcoholic Fatty 64 Treatment Naive 64 Therapy Reduces 64 Systemic Sclerosis 64 Androgen Deprivation Therapy 64 Skin Lesions 64 Phase III Pivotal Trial 64 Benign Prostatic Hyperplasia 64 Intervention Effectiveness CATIE 64 Successfully Treated 64 Total Hip Replacement 64 Pulmonary Artery 64 Contrast Agent 64 BERKELEY CA UroToday.com 64 Esophageal 64 Naive Patients 64 CABANA 64 Phase IIIb 64 ARIXTRA 64 Diabetic Foot Ulcer 64 Accelerated Partial Breast Irradiation 64 Phase Ib Clinical Trial 64 Novel Mechanism 64 Neovascular Age Related Macular 64 Contrast Agents 64 drug eluting stent implantation 64 Peginterferon 64 Vertebral Compression Fractures 64 invasive aspergillosis 64 Malignancies 64 RE MODEL 64 Surgical Procedures 64 Diabetic Macular Edema 64 Initiates Clinical Trial 64 Mitral Regurgitation 64 Urinary Incontinence 64 Carotid Artery 64 C Reactive Protein 64 Inhaled Nitric Oxide 64 Coronary Disease 64 Lung Cancer Screening 64 Coronary Syndromes 64 Spinal Fusion 64 Diffuse Large B 64 Increased Risk 64 Mycophenolate Mofetil 64 heparin induced thrombocytopenia 64 Granted Orphan Drug 64 Clopidogrel 64 Endoprosthesis 64 Treatment Reduces 64 deep venous thromboses 64 Long Term Survival 64 Cost Effectiveness 64 Myelodysplastic Syndrome MDS 63 Intervention Effectiveness 63 Previously Untreated 63 catheter occlusion 63 Adverse Outcomes 63 Eluting Coronary Stent System 63 Prostate Biopsy 63 Therapy Evaluation 63 Bloodstream Infections 63 XIENCE V PROMUS Stent 63 Placebo Controlled 63 Prognostic Factors 63 Hemorrhagic Stroke 63 Initiates Phase III 63 Nephrectomy 63 Osteoporosis Drugs 63 Mortality Risk 63 Stent System 63 Systematic Review 63 Lymph Node 63 Anti Tumor Activity 63 paclitaxel eluting stents 63 recurrent glioma 63 Demonstrated Significant 63 Adjunctive 63 Multivessel Evaluation 63 Mitral Valve Repair 63 recurrent glioblastoma multiforme 63 Differential Diagnosis 63 Major Adverse Cardiac 63 Implantable Defibrillator 63 Acute Coronary 63 Coronary CTA 63 Arrhythmias 63 Thrombus 63 Atherothrombosis 63 ENDEAVOR IV 63 Lowers Risk 63 Left Ventricular Hypertrophy 63 Paroxysmal Atrial Fibrillation 63 Left Atrial Appendage 63 Breast Carcinoma 63 IN PATIENTS WITH 63 achieved CCyR 63 Kidney Transplant Recipients 63 RE LY ® 63 Organ Rejection 63 Scandinavian Simvastatin Survival 63 Percutaneous Coronary Interventions 63 Shows Promise Against 63 INTEGRILIN R 63 Pregnancy Outcomes 63 Cilostazol 63 multicenter randomized clinical 63 Hypercholesterolemia 63 Embolic Protection 63 Thromboembolic 63 Confirms Efficacy 63 Implantable Cardioverter Defibrillators 63 Treatment Naïve 63 Complication Rates 63 Pharmacokinetics PK 63 CARDIOVASCULAR 63 Diabetic Neuropathic Pain 63 Neuroprotective Effects 63 TM Drug Eluting 63 Gastrointestinal Stromal Tumors 63 Adenoma 63 Implantable Device 63 Newly Diagnosed 63 Cancer Diagnosis 63 unstable angina pectoris 63 STEMI 63 Lung Function 63 invasive candidiasis 63 Blood Cancers 63 Esophageal Cancer 63 Ventricular Arrhythmias 63 prospective multicenter randomized 63 Acute Renal Failure 63 Anthracycline 63 Eculizumab 63 Coronary Arteries 63 Initiate Clinical Trial 63 Pivotal Trials 63 Spectrum Pharmaceuticals Announces 63 Heart Failure 63 MADIT 63 Achieves Primary Endpoint 63 Critical Limb Ischemia CLI 63 Peptic Ulcer 63 Revascularization 63 THAT ARE DIFFICULT TO 63 Infected Patients 63 Confirmatory Phase 63 Phase IIa Clinical Trial 63 Liver Tumors 63 Breast Cancers 63 Blood Clots 63 Image Guided 63 Surgical Mesh 63 relapsing multiple sclerosis 63 Arterial Disease 63 Suicidality 63 MADIT II 63 Relapsed Refractory 63 Colorectal Cancers 63 Cholesterol Lowering Drug 63 FDA APPROVES 63 Lung Cancer Survival 63 Targeted Therapy 63 Subcutaneous 63 Myocardial Perfusion 63 GP IIb IIIa inhibitors 63 Chronic Bronchitis 63 Slow Progression 63 renal artery stenting 63 Bypass Surgery 63 Hyperlipidemia 63 Plaque Psoriasis 63 Acute MI 63 Anticoagulants 63 Surgery Performed 63 Anticoagulant 63 Phase 2a Trial 63 Peripheral Artery Disease 63 Anticancer Activity 63 Trial Evaluating 63 Renal Cancer 63 NDA Submission 63 Significantly Reduced 63 Acute Migraine 63 Long Lesion 63 Central Retinal Vein 63 vs. Angiography 63 Blood Pressure Reduction 63 Heart Transplantation 63 Non Inferiority 63 registrational Phase 63 Randomized Clinical Trials 63 ECASS 63 Phase III Clinical Trials 63 Autoimmune Diseases 63 multicenter multinational 63 Capsule Endoscopy 63 Allogeneic 63 Increases Risk 63 Cardiomyocytes 63 Virus Infection 63 Life Threatening 63 ENDEAVOR III 63 stent DES 63 Brentuximab Vedotin SGN 63 Significantly Reduces 63 metastatic malignant 63 Lesion 63 Neoplasms 63 Placebo Controlled Study 63 TO AVOID PREGNANCY WHILE 63 Stent Placement 63 Xelox 63 Spine Patient Outcomes 63 Therapy Shows Promise 63 Embolization 63 carotid artery stenting 63 Dialysis Outcomes 63 ST elevation myocardial 63 Ablation 63 Polyneuropathy 63 Percutaneous Transluminal Coronary Angioplasty 63 Patient Registry 63 Asymptomatic 63 Oncologic 63 Periodontal Disease 63 VADT 63 Efficacy Study 63 Stenting Trial 63 Therapeutic Efficacy 63 Nitinol Stent 63 Premenopausal Women 63 Cancer Treatments 63 Newly Diagnosed Patients 63 Sudden Cardiac Death 63 CORD II 63 ONTARGET 62 Prostate Surgery 62 acute peripheral arterial 62 Cognitive Function 62 Squamous Cell Carcinoma 62 Advanced Solid Tumors 62 Preterm Infants 62 Phase III AFFIRM 62 Myoblast 62 prospective randomized controlled 62 Blocked Arteries 62 Stem Cell Transplants 62 Topline Results 62 Clinical Antipsychotic Trials 62 Hip Fractures 62 Adverse Event 62 Newly Diagnosed Breast Cancer 62 CHARM Added 62 Sirolimus Eluting 62 Digital Mammographic Imaging 62 Reduced Risk 62 Bone Marrow Transplants 62 Effective Treatments 62 HER2 Positive 62 Prospective Cohort Study 62 Comorbidities 62 NEVO RES 62 tumor lysis syndrome 62 NSABP B 62 Estrogen Therapy 62 Partial Nephrectomy 62 Adalimumab 62 BRIM2 62 Lenalidomide 62 Carcinomas 62 coronary intervention 62 Rotavirus Vaccine 62 phase IIIb 62 Versus Placebo 62 Study Shows Promise 62 Genetic Markers 62 Radiofrequency Ablation RFA 62 Randomized Placebo Controlled Trial 62 VerifyNow 62 Single Incision 62 tirofiban 62 Critical Limb Ischemia 62 Transcatheter Aortic Valve Implantation 62 Endometrial 62 Physical Function 62 Rectal Cancer 62 Benign Prostatic Hyperplasia BPH 62 Randomised Study 62 Antiepileptic Drugs 62 Prevent Heart 62 CHAMPION PCI 62 FDG-PET/CT 62 Diagnostic Accuracy 62 Kidney Transplantation 62 Fractional Flow Reserve 62 Slows Progression 62 TAXUS ® 62 Systemic Lupus Erythematosus SLE 62 cinacalcet 62 Occlusions 62 WallFlex Biliary RX 62 Sexual Function 62 Dendritic Cells 62 Sentinel Lymph Node Biopsy 62 randomized multicenter trial 62 Diabetic Foot Ulcers 62 CCX# B 62 reinfarction 62 Transradial 62 Degarelix 62 Adjunctive Therapy 62 #-# Full Text 62 Shows Statistically Significant 62 Nymox NX 62 TRITON TIMI 62 Mouse Model 62 Cardiol 62 Osteoporosis Treatment 62 Clinical Relevance 62 R lenalidomide 62 Improved Outcomes 62 coronary revascularization 62 Microplasmin 62 Replacement Therapy 62 Renal Insufficiency 62 Pharmacodynamics 62 Treatment Approaches 62 Randomised Trial 62 USpella 62 Oral Cavity 62 Renal Transplantation 62 assessing T DM1 62 Cancer Recurrence 62 Subtypes 62 CYPHER R Sirolimus Eluting 62 Ureteral 62 Melphalan 62 Iron Overload 62 Advanced Ovarian Cancer 62 Vascular Disease 62 Insulin Sensitivity 62 Helps Predict 62 TAXUS TM 62 Dose Response 62 Brain Atrophy 62 familial amyloidotic polyneuropathy FAP 62 Renal Tumors 62 Score TOS 62 prospective multicenter study 62 Myocardial Perfusion Imaging 62 Heart Failure Therapies 62 Treatment Experienced 62 occlusion CRVO 62 Medication Adherence 62 ischemic complications 62 IND Filing 62 superficial femoral 62 Prostatic 62 Minimally Invasive Procedure 62 Histologic 62 BOLDER II 62 ischemia driven 62 Hematological 62 percutaneous transluminal coronary angioplasty 62 Anti Clotting Drug 62 Acute Coronary Syndromes ACS 62 CIMZIA TM certolizumab pegol 62 Anti Tumor 62 DuraHeart TM 62 rosuvastatin #mg 62 Insulin Glargine 62 Liver Cancer 62 Hemolysis 62 Postmenopausal Osteoporosis 62 Bone Fracture 62 REALITY Trial 62 Hepatitis C Genotype 62 National Emphysema Treatment 62 carotid endarterectomy CEA 62 myocardial infarction ventricular fibrillation 62 multicentre randomized controlled 62 Antiviral Therapy 62 External Beam 62 biliary tract cancer 62 IMPACT DCM 62 Multicenter Randomized Double 62 Community Acquired Pneumonia 62 Hepatotoxicity 62 Hospital Acquired Pneumonia 62 Platinol ® 62 Bipolar Depression 62 Prostate AdenoCarcinoma Treatment 62 Myelodysplastic Syndrome 62 Randomized Comparison 62 Treating Depression 62 everolimus eluting stent 62 BR.# 62 Chronic HCV 62 sunitinib Sutent 62 Refractory Hodgkin Lymphoma 62 metastatic castration resistant 62 XIENCE V Everolimus Eluting 62 Coronary Artery Disease 62 Eluting 62 NEVO 62 Functional Outcomes 62 Effectively Treats 62 Allergic Rhinitis 62 Hematologic 62 Unstable angina 62 Who Underwent 62 Glycemia 62 Patient Treated 62 MIST II 62 Peginterferon Alfa 2a 62 Motexafin Gadolinium 62 Renal dysfunction 62 Tocilizumab 62 CABERNET 62 Ventricular Assist Devices 62 Multicentre 62 Anticancer Drug 62 Pirfenidone 62 underwent resection 62 Initiates Phase 2b 62 Spinal Disc 62 Eur J 62 Trial NLST 62 Interventional Procedures 62 Vascular Grafts 62 Cypher Stent 62 Feasibility Trial 62 Celecoxib APC trial 62 evaluating mipomersen 62 Tumor Progression 62 Significantly Improves 62 Therapy Improves 62 HORIZONS AMI 62 acute coronary syndromes ACS 62 CLINICAL PHARMACOLOGY 62 Exacerbation 62 Hematopoietic Stem Cell Transplantation 62 Expanded Indication 62 Left Atrial 62 Transdermal Patch 62 aneurysms AAA 62 rFVIIa 62 Drug Resistant 62 Computer Aided Detection 62 candesartan cilexetil 62 Bucindolol Based 62 Vascugel ® 62 Hsp# Inhibitor 62 prospective multicentre